Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells

被引:45
作者
Lee, Hye Myeong [1 ]
Jeong, Young-Il [1 ]
Kim, Do Hyung [1 ,2 ]
Kwak, Tae Won [1 ]
Chung, Chung-Wook [1 ]
Kim, Cy Hyun [1 ,2 ]
Kang, Dae Hwan [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Natl Res & Dev Ctr Hepatobiliary Canc, Res Inst Convergence Biomed Sci & Technol, Gyeongnam 626770, South Korea
[2] Pusan Natl Univ, Sch Med, Yangsan 626770, Gyeongnam, South Korea
关键词
Ursodeoxycholic acid; Cholangiocarcinoma; Chlorin e6; Chitosan; Photodynamic therapy; CHLORIN E(6); THERAPY; NANOPARTICLES; DELIVERY; CANCER; E6; PROLIFERATION; PROTEIN; FOLATE;
D O I
10.1016/j.ijpharm.2013.06.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chitosan was hydrophobically modified with ursodeoxycholic acid (UDCA) to fabricate nano-photosensitizer for photodynamic therapy (PDT) of HuCC-T1 cholangiocarcinoma cells. Synthesis of UDCA-conjugated chitosan (ChitoUDCA) was confirmed using H-1 NMR spectra. Chlorin E6 (Ce6) was used as a photosensitizer and incorporated into ChitoUDCA nanoparticles through formation of ion complexes. Morphology of Ce6-incorporated ChitoUDCA nanoparticles was observed using TEM and their shapes were spherical with sizes around 200-400 nm. The PDT potential of Ce6-incorporated ChitoUDCA nanoparticles were studied with HuCC-T1 human cholangiocarcinoma cells. The results showed that ChitoUDCA nanoparticles enhances of Ce6 uptake into tumor cells, phototoxicity, and ROS generation compared to Ce6 itself. Furthermore, Ce6-incorporated ChitoUDCA nanoparticles showed quenching in aqueous solution and sensing at tumor cells. We suggest that Ce6-incorporated ChitoUDCA nanoparticles are promising candidates for PDT of cholangiocarcinoma cells. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 47 条
[1]  
Akhlynina TV, 1999, INT J CANCER, V81, P734, DOI 10.1002/(SICI)1097-0215(19990531)81:5<734::AID-IJC12>3.0.CO
[2]  
2-J
[3]   Radiotherapy and Chemotherapy as Therapeutic Strategies in Extrahepatic Biliary Duct Carcinoma [J].
Brunner, Thomas B. ;
Eccles, Cynthia L. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (12) :672-680
[4]   Endoscopic palliation of cholangiocarcinoma [J].
Chahal, Prabhleen ;
Baron, Todd H. .
CURRENT OPINION IN GASTROENTEROLOGY, 2006, 22 (05) :551-560
[5]   Cholangiocarcinoma treatment [J].
Halim Charbel ;
Firas H. Al-Kawas .
Current Gastroenterology Reports, 2012, 14 (6) :528-533
[6]   Ursodeoxycholic acid-induced inhibition of DLC1 protein degradation leads to suppression of hepatocellular carcinoma cell growth [J].
Chung, Goh Eun ;
Yoon, Jung-Hwan ;
Lee, Jeong-Hoon ;
Kim, Hwi Young ;
Myung, Sun Jung ;
Yu, Su Jong ;
Lee, Sung-Hee ;
Lee, Soo-Mi ;
Kim, Yoon Jun ;
Lee, Hyo-Suk .
ONCOLOGY REPORTS, 2011, 25 (06) :1739-1746
[7]   Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells [J].
Chung, Kyu-Don ;
Jeong, Young-Il ;
Chung, Chung-Wook ;
Kim, Do Hyung ;
Kang, Dae Hwan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 422 (1-2) :454-461
[8]   Primary biliary cirrhosis and bile acids [J].
Corpechot, Christophe .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 :S13-S20
[9]   Photodynamic therapy for cancer [J].
Dolmans, DEJGJ ;
Fukumura, D ;
Jain, RK .
NATURE REVIEWS CANCER, 2003, 3 (05) :380-387
[10]   Photodynamic therapy [J].
Dougherty, TJ ;
Gomer, CJ ;
Henderson, BW ;
Jori, G ;
Kessel, D ;
Korbelik, M ;
Moan, J ;
Peng, Q .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (12) :889-905